Literature DB >> 28028718

Recent highlights of Chinese medicine for advanced lung cancer.

Xi-Ran He1, Shu-Yan Han1, Ping-Ping Li2.   

Abstract

Owing to its unique superiority in improving quality of life and prolonging survival time among advanced lung cancer patients, Chinese medicine (CM) has, in recent years, received increased attentions worldwide. We utilized a bibliometric statistical method based on MEDLINE/GoPubMed to conduct a comprehensive analysis of the current application status of CM in lung cancer, by including annual and accumulated publications, origin distribution of countries and journals, and keywords with a higher frequency score. Then the relevant clinical trials and mechanistic studies were systematically summarized within the field according to research types. We have raised potential problems and provided potentially useful reference information that could guide similar studies in the future. The basic experimental results are highly consistent with clinical trials, leading us to conclude that CM can offer better overall therapeutic benefits when used in combination with routine Western medicine for patients with advanced lung cancer.

Entities:  

Keywords:  Chinese medicine; advanced lung cancer; clinical trials; experimental researches; latest progress

Mesh：

Year:  2016        PMID： 28028718     DOI： 10.1007/s11655-016-2736-2

Source DB:  PubMed          Journal:  Chin J Integr Med        ISSN： 1672-0415            Impact factor:   1.978


  40 in total

1.  Combined therapy of percutaneous cryoablation and traditional Chinese medicine can be a promising strategy for elderly or advanced lung cancer patients based on a retrospective clinical study.

Authors:  Lei Gao; Quanwang Li; Min Jiang; Chuanbo Liu; Zilin Song; Xiaoling Bao; Yang Shen; Guijian Liu; Kaiwen Hu
Journal:  Cryobiology       Date:  2014-05-23       Impact factor: 2.487

Review 2.  Systematic review of acupuncture in cancer care: a synthesis of the evidence.

Authors:  M Kay Garcia; Jennifer McQuade; Robin Haddad; Sonya Patel; Richard Lee; Peiying Yang; J Lynn Palmer; Lorenzo Cohen
Journal:  J Clin Oncol       Date:  2013-01-22       Impact factor: 44.544

3.  Astragalus polysaccharide injection integrated with vinorelbine and cisplatin for patients with advanced non-small cell lung cancer: effects on quality of life and survival.

Authors:  Li Guo; Shu-Ping Bai; Ling Zhao; Xiao-Hong Wang
Journal:  Med Oncol       Date:  2011-09-18       Impact factor: 3.064

4.  Application of Response Evaluation Criteria of Traditional Chinese Medicine for Solid Tumor in advanced non-small cell lung cancer.

Authors:  Nuan-Zhu Xue; Ruo-Ming Fang; Li-Zhu Lin
Journal:  Chin J Integr Med       Date:  2014-11-27       Impact factor: 1.978

5.  New cytotoxic 19-norbufadienolide and bufogargarizin isolated from Chan Su.

Authors:  Hu Chen; Yu-Hui Meng; De-An Guo; Xuan Liu; Jun-Hua Liu; Li-Hong Hu
Journal:  Fitoterapia       Date:  2015-05-15       Impact factor: 2.882

6.  [Effects of Feiji Formula on lung cancer metastasis in mice].

Authors:  Jian-hui Tian; Zhi-ming Shi; Zhi-yi Zhou; Yun-sheng Huang; Lin Wang
Journal:  Zhong Xi Yi Jie He Xue Bao       Date:  2008-08

7.  [Effect of Japanese traditional medicine, TJ-41, on quality of life of patients with non-small cell lung cancer receiving outpatient chemotherapy].

Authors:  Yoshihisa Ishiura; Hiroki Yamamoto; Yasutaka Shiba; Yasushi Terasaki; Youichi Ishida; Fumiko Tanikawa; Hideko Hayase; Kazumi Maruyama; Chiemi Obata; Mika Ishikawa; Kazunori Hirokami; Kazuo Kasahara; Masaki Fujimura
Journal:  Gan To Kagaku Ryoho       Date:  2013-07

8.  [Gefitinib target treatment in non-small cell lung cancer].

Authors:  Yi-long Wu; Jin-ji Yang; Jia-ying Lin; Yu-juan Huang; Ri-qiang Liao; Yi-sheng Huang; Qing Zhou; Chong-rui Xu; Zhen Wang
Journal:  Zhonghua Jie He He Hu Xi Za Zhi       Date:  2007-02

Review 9.  Traditional Chinese medicinal herbs combined with epidermal growth factor receptor tyrosine kinase inhibitor for advanced non-small cell lung cancer: a systematic review and meta-analysis.

Authors:  Zhong-liang Liu; Wei-rong Zhu; Wen-chao Zhou; Hai-feng Ying; Lan Zheng; Yuan-biao Guo; Jing-xian Chen; Xiao-heng Shen
Journal:  J Integr Med       Date:  2014-07

10.  Comparison of efficacy and toxicity of traditional Chinese medicine (TCM) herbal mixture LQ and conventional chemotherapy on lung cancer metastasis and survival in mouse models.

Authors:  Lei Zhang; Chengyu Wu; Yong Zhang; Fang Liu; Xiaoen Wang; Ming Zhao; Robert M Hoffman
Journal:  PLoS One       Date:  2014-10-06       Impact factor: 3.240
View more
  3 in total

1.  Self-Expandable Metallic Stent Implantation Combined With Bronchial Artery Infusion Chemoembolization in the Treatment of Lung Cancer With Complete Atelectasis.

Authors:  Xiaobing Li; Meipan Yin; Pengfei Xie; Ying Liu; Xiangnan Li; Yu Qi; Yaozhen Ma; Chunxia Li; Gang Wu
Journal:  Front Oncol       Date:  2022-01-12       Impact factor: 6.244

2.  Chinese Medicine Combined With EGFR-TKIs Prolongs Progression-Free Survival and Overall Survival of Non-small Cell Lung Cancer (NSCLC) Patients Harboring EGFR Mutations, Compared With the Use of TKIs Alone.

Authors:  Yujia Wang; Guoyu Wu; Ru Li; Yingzhe Luo; Xingmei Huang; Lifang He; Huihui Zhong; Shaoquan Xiong
Journal:  Front Public Health       Date:  2021-06-18

3.  Ailanthone inhibits non-small cell lung cancer cell growth through repressing DNA replication via downregulating RPA1.

Authors:  Zhongya Ni; Chao Yao; Xiaowen Zhu; Chenyuan Gong; Zihang Xu; Lixin Wang; Suyun Li; Chunpu Zou; Shiguo Zhu
Journal:  Br J Cancer       Date:  2017-10-12       Impact factor: 7.640
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.